Adhesion of adenosine diphosphate-activated platelets to human brain microvascular endothelial cells under flow in vitro is mediated via GPIIb/IIIa

Neurosci Lett. 2001 Mar 23;301(1):33-6. doi: 10.1016/s0304-3940(01)01608-1.

Abstract

Employing video-enhanced contrast (VEC) microscopy, we examined whether TAK-029 (GPIIb/IIIa antagonist) inhibits the adhesion of activated platelets to human brain microvascular endothelial cells (HBEC) in vitro. HBECs were cultured on a coverglass and put in the observation chamber of VEC microscopy. Then, activated platelets by adenosine diphosphate (ADP) (2 microM) were perfused over HBEC at a low shear rate of 10 s(-1) for 30 min and washed out. Platelets adhered directly to HBEC. However, platelet adhesion to HBEC was suppressed when platelet rich plasma with ADP (2 microM) plus TAK-029 (GPIIb/IIIa antagonist; 1 microM) was perfused over HBEC for 30 min and washed out. Anti-GPIbalpha antibody (GUR20-5) did not inhibit adhesion of ADP-activated platelets to HBEC. The above results showed adhesion of ADP-activated platelets to HBEC under flow in vitro is mediated via GPIIb/IIIa

MeSH terms

  • Adenosine Diphosphate / pharmacology
  • Brain / blood supply*
  • Cells, Cultured
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / physiology
  • Fibrinolytic Agents / pharmacology*
  • Guanidines / pharmacology*
  • Humans
  • Microcirculation
  • Platelet Adhesiveness / drug effects*
  • Platelet Adhesiveness / physiology
  • Platelet Aggregation / drug effects
  • Platelet Aggregation / physiology
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
  • Platelet Glycoprotein GPIIb-IIIa Complex / physiology
  • Pyrazines / pharmacology*

Substances

  • Fibrinolytic Agents
  • Guanidines
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Pyrazines
  • Adenosine Diphosphate
  • TAK 029